Investor Relations

AN INNOVATIVE COMPANY

– with potential for good value development

AN INNOVATIVE COMPANY

– with potential for good value development

4 reasons to invest

in NanoEcho

In a short time, NanoEcho has transitioned from being a research-focused company to today being a medical technology product development company, with both clinical and commercial focus.

Rapidly growing demand for reliable rectal cancer diagnostics

NanoEcho has developed an innovative method with significant market potential

Potential to generate substantial health economic benefits

A dynamic company with high intellectual capital

Contact

Matilda Almqvist

PR and Communication

E-mail: ir@nanoecho.se

NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.

NanoEcho AB
Scheelevägen 19,
223 63 Lund
info@nanoecho.se